A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU)
Latest Information Update: 17 Jan 2024
Price :
$35 *
At a glance
- Drugs Ustekinumab (Primary) ; Prednisone
- Indications Oedema; Uveitis
- Focus Proof of concept; Therapeutic Use
- 17 Jan 2024 New trial record